←Back to Expert Scholars
Translational Medicine / 转化医学Ki67 & Proliferation
Meredith Regan
ScD
🏢Dana-Farber Cancer Institute / Harvard Medical School🌐USA
Professor of Medicine
72
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Meredith Regan is a senior biostatistician leading analyses for BIG and IBCSG international breast cancer trials. She has evaluated Ki67 as prognostic and predictive factors across multiple adjuvant studies. Her statistical frameworks shape biomarker interpretation in breast cancer research.
Share:
🧪Research Fields 研究领域
Biostatistics
BIG-IBCSG trials
Endocrine therapy trials
Biomarker statistics
Ki67 analytical methods
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Meredith Regan 的研究动态
Follow Meredith Regan's research updates
留下邮箱，当我们发布与 Meredith Regan（Dana-Farber Cancer Institute / Harvard Medical School）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment